deficiency of growth hormone in children. Re-evaluation after therapeutic completion.

Authors

  • T Martins Serviço de Endocrinologia, Diabetes e Metabolismo, Hospitais da Universidade de Coimbra, Coimbra.
  • M Bastos
  • P Leitão
  • L Barros
  • L Ruas
  • C Batista
  • S Paiva
  • M Carvalheiro
  • M M Ruas

DOI:

https://doi.org/10.20344/amp.1802

Abstract

To assess GH secretion in young adults treated with GH replacement therapy in childhood.From the 38 patients who concluded treatment with GH, we studied 20 (52.6%), 9 girls and 11 boys. Thirteen had Growth Hormone Deficiency (GHD)-65%, while 7 had Multiple Pituitary Hormone Deficiency (MPHD)-35%. The patients were retested within 6 months to 6 years after completing GH therapy. The mean age (+/- SD) at retesting was 18.1 +/- 2.6 years for those with GHD and 20.8 +/- 2.8 for those with MPHD. At reassessment we performed two provocative tests: insulin tolerance test (ITT) and clonidine test.Seven of the 20 patients retested, retained GH deficiency. Of the 13 patients with GHD, only one maintained the deficiency, while of the 7 patients with MPHD, 6 maintained the deficiency.Young adults with GH deficiency treated with this hormone should be retested in order to identify those who are truly GH insufficient adults and may benefit from replacement therapy.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Martins T, Bastos M, Leitão P, Barros L, Ruas L, Batista C, Paiva S, Carvalheiro M, Ruas MM. deficiency of growth hormone in children. Re-evaluation after therapeutic completion. Acta Med Port [Internet]. 2000 Dec. 30 [cited 2024 Nov. 23];13(5-6):283-5. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/1802

Issue

Vol. 13 No. 5-6 (2000): Setembro-Dezembro

Section

Arquivo Histórico

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC